| Literature DB >> 29580265 |
Kei Nakajima1, Eiichiro Kanda2, Kaname Suwa3.
Abstract
OBJECTIVE: Hearing loss may be associated with certain sleep abnormalities. We recently reported that subclinical hearing loss (SHL) was more prevalent in individuals in a broad Japanese population who slept longer than 8 h; however, the underlying mechanism was unknown. Therefore, we investigated the association between SHL and self-reported restorative sleep (RS), assessed by questionnaire, in a database of 33,888 Japanese aged 40-69 years without overt or diagnosed hearing loss (20,225 men, 13,663 women).Entities:
Keywords: Age-related hearing loss; Bilateral hearing loss; Cardiometabolic risk; Cognitive impairment; Hearing loss; High frequency; Restorative sleep
Mesh:
Year: 2018 PMID: 29580265 PMCID: PMC5870928 DOI: 10.1186/s13104-018-3315-8
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Characteristics of subjects classified according to presence of SHL at 4000 Hz
| Characteristic | Intact hearing | Unilateral SHL | Bilateral SHL |
|---|---|---|---|
| N (%) | 29,024 (85.6) | 2435 (7.2) | 2429 (7.2) |
| Male, n (%) | 15,911 (54.8) | 2068 (84.9) | 2246 (92.5) |
| Age (years) | 50.7 ± 7.4 | 56.0 ± 7.4 | 58.0 ± 7.2 |
| BMI (kg/m2) | 23.4 ± 3.6 | 23.9 ± 3.2 | 23.7 ± 3.4 |
| Systolic blood pressure (mmHg) | 125 ± 17.1 | 131 ± 16.9 | 132 ± 17.8 |
| Serum triglyceride (mg/dl) | 98 (67–149) | 113 (79–174) | 111 (76–167) |
| Serum HDL-cholesterol (mg/dl) | 60.2 ± 15.3 | 56.6 ± 15.0 | 55.3 ± 14.5 |
| HbA1c (NGSP, %) | 5.66 ± 0.7 | 5.82 ± 0.8 | 5.87 ± 0.9 |
| Pharmacotherapy for | |||
| Hypertension, n (%) | 4037 (13.9) | 546 (22.4) | 616 (25.4) |
| Diabetes, n (%) | 1031 (3.6) | 171 (7.0) | 202 (8.3) |
| Dyslipidemia, n (%) | 2220 (7.6) | 288 (11.8) | 232 (9.6) |
| Current smokers, n (%) | 7631 (26.3) | 1009 (41.4) | 1129 (46.5) |
| Everyday alcohol consumers, n (%) | 7765 (26.8) | 958 (39.3) | 1127 (46.4) |
| Regular exercisers, n (%)a | 7018 (24.2) | 682 (28.0) | 666 (27.4) |
| Past history of | |||
| CVD, n (%) | 711 (2.5) | 118 (4.8) | 125 (5.1) |
| Stroke, n (%) | 321 (1.1) | 63 (2.6) | 57 (2.3) |
Data are presented as mean ± SD, median (interquartile range), or numbers (%)
All P values determined by ANOVA and χ2 test for continuous and categorical variables, respectively, were < 0.0001. Differences between unilateral and bilateral SHL groups with regard to all continuous and categorical variables between two groups were statistically significant in post hoc Bonferroni testing and an additional χ2 test except for BMI, serum triglyceride, pharmacotherapy for hypertension, regular exercisers, and past history of CVD and stroke
Serum triglyceride concentrations were log-transformed before parametric analysis
BMI body mass index; HDL high-density lipoprotein; CVD cardiovascular disease; SHL subclinical hearing loss
aRegular exercise was defined as ≥ 30 min exercise per session at least twice a week
Fig. 1Proportions of subjects with RS by age-group The small vertical bars represent the standard error with RS numbered as 1 and non-RS as 0. The proportion of subjects with RS in their 50 s and 60 s significantly rose with increasing SHL (P = 0.004 and P = 0.001, respectively, one-way ANOVA). *Significant difference compared with intact hearing (Bonferroni test) in each age-group. RS restorative sleep
Odds ratio (95% confidence interval) of SHL for RS
| SHL at 4000 Hz | Both intact | Unilateral | Bilateral | |
|---|---|---|---|---|
| SSRS, n (%) | 16,544 (57.0) | 1542 (63.3) | 1652 (68.0) | |
| Model 1 | 1 (reference) | 1.30 (1.20–1.42)*** | 1.60 (1.47–1.75)*** | |
| Model 2 | 1 (reference) | 1.05 (0.96–1.15) | 1.21 (1.10–1.32)*** | |
| Model 3 | 1 (reference) | 1.06 (0.97–1.16) | 1.22 (1.11–1.34)*** | |
| Model 3 | ||||
| Men | 1 (reference) | 1.03 (0.94–1.14) | 1.18 (1.10–1.32)** | |
| Women | 1 (reference) | 1.14 (0.92–1.42) | 1.32 (0.96–1.81) | |
Model 1: unadjusted
Model 2: adjustment for age and sex
Model 3: Model 2 plus adjustment for current smoking (versus non-smoking), daily alcohol consumption (versus infrequent/no alcohol consumption), regular exercise (versus no regular exercise), pharmacotherapy (for hypertension, diabetes, or dyslipidemia), BMI, systolic blood pressure, triglyceride, HDL cholesterol, HbA1c (as continuous variables) and past history of CVD or stroke (versus no history)
BMI body mass index; HDL high-density lipoprotein; CVD cardiovascular disease; SHL subclinical hearing loss; RS restorative sleep
* P < 0.05, ** P < 0.01, *** P < 0.0001